The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Natera, Inc. | Common Stock | 632307104 | 13,937 | 1,550,280 | SH | SOLE | 1,550,280 | 0 | 0 | ||
| Aclaris Therapeutics, Inc. | Common Stock | 00461U105 | 37,964 | 1,539,480 | SH | SOLE | 1,539,480 | 0 | 0 | ||
| Auris Medical Holding AG | Common Shares | H03579101 | 4,621 | 7,818,175 | SH | SOLE | 7,818,175 | 0 | 0 | ||
| Histogenics Corporation | Common Stock | 43358V109 | 4,258 | 2,077,040 | SH | SOLE | 2,077,040 | 0 | 0 | ||
| Spark Therapeutics, Inc. | Common Stock | 84652J103 | 24,747 | 481,270 | SH | SOLE | 481,270 | 0 | 0 | ||
| ObsEva SA | Common Stock | H5861P103 | 46,356 | 4,749,623 | SH | SOLE | 4,749,623 | 0 | 0 | ||
| NuCana plc | American Depositary Shares | 67022C106 | 47,180 | 4,666,666 | SH | SOLE | 4,666,666 | 0 | 0 | ||
| Synlogic, Inc. | Common Stock | 87166L100 | 4,122 | 424,972 | SH | SOLE | 424,972 | 0 | 0 | ||